Interestingly, confocal microscopy analysis of human GBM specimens showed that PATZ1 was expressed in the NESTIN+ subpopulation, which has been recently shown to be crucial for tumor recurrence after treatment with the chemotherapeutic agent temozolomide [10]. Here, PATZ1 is linked to glioblastoma.